drugset / Trial / NCT01098318

Rhodiola Rosea Therapy of Major Depressive Disorder

NCT01098318

RandomizedParallel-groupTriple-blindTreatment

Summary

Prior research has shown that Rhodiola rosea may be an effective, short-term, anti-depressant therapy. This study will examine the anti-depressant effect of Rhodiola rosea vs. a conventional, anti-depressant drug in the treatment of major depression.

Timeline

Start
2010-06
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Rhodiola Traditional medicine (herbal / TCM) 340 mg
Subject Rhodiola Traditional medicine (herbal / TCM) 1360 mg
Comparator Sertraline Small molecule 50 mg
Comparator Sertraline Small molecule 200 mg

Indications